Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright restated their buy rating on shares of Aadi Bioscience (NASDAQ:AADI – Free Report) in a research note issued to investors on Thursday, MarketBeat.com reports. They currently have a $45.00 price target on the stock. HC Wainwright also issued estimates for Aadi Bioscience’s FY2024 earnings at ($2.98) EPS. Separately, LADENBURG THALM/SH SH lowered their […]
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "PEComa - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides in-depth insights into PEComa, including historical and forecasted epidemiology, market trends, and treatment practices in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan. Market Assessment: The report covers current treatment practices, emerging drugs, market sha
Aadi Bioscience (NASDAQ:AADI – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Wednesday, August 9th. Analysts expect the company to announce earnings of ($0.64) per share for the quarter. Aadi Bioscience (NASDAQ:AADI – Get Free Report) last posted its earnings results on Wednesday, May 10th. The company […]
On Tuesday, 46 stocks hit new 52-week lows.